Performance Evaluation Of T Company From The Perspective Of Core Technical Staff Equity Incentive

The twenty-first century is an era of technological power,and pharmaceutical R&D companies focused on clinical trials of new drugs are seeing a boom.In order to achieve a high level of technological self-sufficiency,we need to pay attention to the motivation of core technical staff.The core technical staff is the foundation of pharmaceutical companies,and the long and costly development cycle of new drugs requires a stable,high-quality talent pool.The shortcomings of the traditional compensation system make the core technical staff more mobile,and the implementation of equity incentives for the core technical staff is conducive to the unification of individual and collective interests,so as to achieve the purpose of attracting and retaining talents.The thesis takes Company T as the research object and collects relevant research data by reviewing literature and field research.Firstly,we analyze the current situation of performance evaluation of Company T from the perspective of equity incentive of core technical personnel,and find that Company T has problems such as imperfect performance evaluation system,unreasonable index setting and uncritical evaluation results.Secondly,based on the successful experience of performance evaluation at home and abroad,we used the balanced scorecard and efficacy coefficient method to build the performance evaluation system of Company T based on the perspective of core technical staff equity incentive and applied it.Finally,based on the performance evaluation results of the implementation of core technical staff equity incentive in Company T,the internal guarantee measures are proposed in three aspects:optimizing the performance management strategy,improving the performance evaluation mechanism,and implementing different incentive measures,while the external guarantee is strengthened by improving the laws and regulations of equity incentive,strengthening the supervision of equity incentive performance,and creating a sharing platform for technical staff.Through the thesis research,we provide guidance for the performance evaluation of T companies,and expect to provide useful references for pharmaceutical R&D companies to improve their equity incentive schemes and strengthen their performance evaluation,so as to promote the sustainable development of the industry.